Lars Thorsson
Chief Tech/Sci/R&D Officer presso CANTARGIA AB
Patrimonio netto: 46 135 $ in data 31/03/2024
Provenienza dei contatti di primo grado di Lars Thorsson
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
22
| Public Company | Pharmaceuticals: Major | 22 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Lars Thorsson tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ACTIVE BIOTECH AB | Biotechnology | Investor Relations Contact Corporate Officer/Principal | |
| VITROLIFE AB | Medical Specialties | Chief Executive Officer | |
| RAYSEARCH LABORATORIES AB | Packaged Software | Director of Finance/CFO | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Stockholm | College/University | Undergraduate Degree | |
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Director of Finance/CFO | |
| Technical University of Denmark | College/University | Graduate Degree Graduate Degree | |
| CAMURUS AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Royal Institute of Technology | College/University | Graduate Degree | |
| University of Lund | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Graduate Degree | |
| ENSIMAG | College/University | Graduate Degree | |
| BIOARCTIC AB | Pharmaceuticals: Major | Director of Finance/CFO | |
Isogenica Ltd.
 Isogenica Ltd. Miscellaneous Commercial ServicesCommercial Services Isogenica Ltd. provides research and development services in the fields of new peptide, antibody and other polypeptide drug candidates. It offers llamdA System, Xab System and 4D Fab System. The company was founded by Kevin Fitzgerald in 2000 and is headquartered in Little Chesterford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| Sunstone LSV General Partner I ApS | Corporate Officer/Principal | ||
Extenda AB
 Extenda AB Information Technology ServicesTechnology Services Extenda AB develops point-of-sale technology (POS) solutions. Its product suite include transaction engine, selfscan, mobile POS, and self checkout. The firm also offers support, service and maintenance, and catalogue services. The company was founded by Peter Carlman in 1982 and is headquartered in Stockholm, Sweden. | Information Technology Services | Director of Finance/CFO | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Investor Relations Contact | |
| QLUCORE AB | Packaged Software | Founder | |
| GUARD THERAPEUTICS INTERNATIONAL AB | Pharmaceuticals: Major | Director/Board Member | |
| MENDUS AB | Biotechnology | Director/Board Member Director/Board Member | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director of Finance/CFO | |
Forendo Pharma Oy
 Forendo Pharma Oy Pharmaceuticals: MajorHealth Technology Forendo Pharma Oy provides novel pharmaceutical treatments for endometriosis and low testosterone levels. Its product fispemifene is the first selective estrogen receptor modulator designed only for men, which helps for the treatment of symptoms of low testosterone, in phase II clinical studies in men with secondary hypogonadism; fispemifene has normalized the low testosterone levels. Its 17HSD1-inhibitor focuses on endometriosis, is a potent and selective lead compounds demonstrated in vivo proof of efficacy in disease model of endometriosis. The company was founded by Risto Arvo Sakari Lammintausta in 2013 and is headquartered in Turku, Finland. | Pharmaceuticals: Major | Director/Board Member | |
| Sunstone LSV General Partner BI ApS | Corporate Officer/Principal | ||
| Sunstone LSV Partners & Co. Holding III ApS | Chief Executive Officer | ||
| Sunstone LSV Partners Holding III ApS | Chief Executive Officer | ||
| Sunstone LSV Invest III Holding ApS | Chief Executive Officer | ||
| Sunstone LSV & Co. Special Limited Partner III Holding ApS | Chief Executive Officer | ||
| Sunstone LSV Invest III ApS | Chief Executive Officer | ||
| Sunstone LSV Special Limited Partner III Aps | Chief Executive Officer | ||
| Sunstone Lsv Special Ltd. Partner Iii Holding Aps | Chief Executive Officer | ||
Acarix A/S
 Acarix A/S Medical SpecialtiesHealth Technology Acarix A/S engages in development, production and advertisement of a new cardiovascular diagnostic methods and equipment. It develops engages in the non-invasive and non-radiation acoustic detection of coronary artery disease. The firm designs CADScor, a sensor that records, processes, and displays heart signal. The company was founded in 2009 and is headquartered in Kongens Lyngby, Denmark. | Medical Specialties | Director/Board Member | |
| Oncopeptides Incentive AB | Director/Board Member | ||
| Sciencecap Stockholm AB | Director/Board Member | ||
Sunstone Life Science Ventures A/S
 Sunstone Life Science Ventures A/S Financial ConglomeratesFinance Part of Sunstone Capital A/S, Sunstone Life Science Ventures A/S is a Danish company that provides investment services. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
ReWind Therapeutics NV
 ReWind Therapeutics NV Pharmaceuticals: MajorHealth Technology ReWind Therapeutics NV is a biotech company based in Leuven, Belgium that develops first-in-class remyelinating therapies for myelin-related diseases. The Belgian company's aim is to bring these therapies into fast-track clinical development. Myelin-related diseases, such as multiple sclerosis, are those where the myelin sheath surrounding nerves is damaged, leading to deficient nerve transmission that may affect multiple functions, including sensation, cognition, and movement, among others. ReWind Therapeutics develops first-in-class therapeutics designed to re-initiate the process of remyelination in patients suffering from major debilitating diseases such as multiple sclerosis, optic neuritis, or nerve injuries. The company's team has extensive R&D expertise and has built a strong patent estate for developing novel remyelination therapeutics. The company was founded in 2017 by Ku Leuven's Centre for Drug Design and Discovery (CD3) and Axxam S.p.A. The CEO of the company since 2021 is Anja Harmeier. | Pharmaceuticals: Major | Director/Board Member | |
Latentix ApS
 Latentix ApS Information Technology ServicesTechnology Services Latentix ApS provides custom computer programming services. The private company is based in Frederiksberg, Denmark. | Information Technology Services | Corporate Officer/Principal | |
Sunstone Tv Lsv Special LP Ill Aps
 Sunstone Tv Lsv Special LP Ill Aps Financial ConglomeratesFinance Sunstone Tv Lsv Special LP Ill Aps is an investment holding Danish company. The private company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Sunstone LSV General Partner Ill ApS
 Sunstone LSV General Partner Ill ApS Financial ConglomeratesFinance Part of Sunstone Capital A/S, Sunstone LSV General Partner Ill ApS functions as an investment holding Danish company. The private company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Abinitio ApS
 Abinitio ApS Financial ConglomeratesFinance Abinitio ApS is an investment holding Danish company. The private company is based in Copenhagen, Denmark. The CEO of the company is Claus Asbjørn Andersson. | Financial Conglomerates | Chief Executive Officer | |
Sunstone Lsv General Partner Ii ApS
 Sunstone Lsv General Partner Ii ApS Financial ConglomeratesFinance Sunstone Lsv General Partner Ii ApS functions as an investment holding Danish company. The private company is based in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
Sunstone Lsv & Co. Invest Ill Holding Aps
 Sunstone Lsv & Co. Invest Ill Holding Aps Financial ConglomeratesFinance Sunstone Lsv & Co. The private company is based in Copenhagen, Denmark. Invest Ill Holding Aps functions as an investment holding Danish company. | Financial Conglomerates | Chief Executive Officer | |
| Asbjørn Andersson ApS | Chief Executive Officer | ||
| Lisa Martin-Löf Konsultbyrå AB | Director/Board Member | ||
A3P Biomedical AB
 A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Medical/Nursing Services | Director of Finance/CFO | |
| COEGIN PHARMA AB | Pharmaceuticals: Major | Director/Board Member Chairman | |
| IO BIOTECH, INC. | Biotechnology | Director/Board Member | |
| Neodos AB | Director/Board Member | ||
| Active Security Trading AB | Director/Board Member | ||
Active Biotech Research AB
 Active Biotech Research AB Pharmaceuticals: MajorHealth Technology Active Biotech Research AB develops pharmaceuticals. The private company is based in Lund, Sweden. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Svezia | 27 |
| Danimarca | 21 |
| Francia | 2 |
| Regno Unito | 2 |
| Finlandia | 2 |
Settori
| Health Technology | 17 |
| Consumer Services | 7 |
| Finance | 7 |
| Technology Services | 5 |
| Commercial Services | 3 |
Posizioni
| Director/Board Member | 93 |
| Corporate Officer/Principal | 44 |
| Chairman | 31 |
| Chief Executive Officer | 26 |
| Independent Dir/Board Member | 23 |
Contatti più connessi
- Borsa valori
- Insiders
- Lars Thorsson
- Connessioni Società
